Wegovy® FlexTouch® 2.4mg (1 Pen)

Wegovy® 2.4 mg (semaglutide) FlexTouch® is the maintenance dose of the standard semaglutide titration protocol. In the STEP clinical trials, patients receiving 2.4 mg weekly achieved a mean body weight reduction of approximately 15% over 68 weeks. Discontinuation of therapy is associated with weight regain. Each single-use FlexTouch® pen contains four weekly doses (one month of therapy), administered as a subcutaneous injection once every seven days.

What's included with every Wegovy® 2.4mg order:

• Authentic Novo Nordisk® Wegovy® 2.4mg FlexTouch® pen
• Cold-chain delivery or in-clinic dispense (2–8°C verified)
• Physician prescription review before dispense
• Visible batch number and expiry on every pen
• Ongoing physician supervision for long-term weight management

Wegovy® is a prescription-only medication in the Philippines. Purchase requires a valid prescription from a licensed physician — available through our online consultation or at our BGC and Quezon City clinics.